Stock AnalizUniversal Health Services Inc. UHS
Hospital/Nursing Management · data as of November 13, 2026
Universal Health Services Inc. (UHS) is a healthcare company listed in the US with a market value of about $11.2B. In the twelve months to September 30, 2026 it had revenue of $18.4B and net income of $1.5B, a net margin of 8.0%.
Its overall Stock Analiz score is 3.8 out of 5 (good). The strongest part is value (5/5); the weakest is future growth (2/5).
Key numbers: a P/E of 8.1, a price to free cash flow of 10.0, 5-year revenue growth of 8% a year, a 5-year average ROIC of 10%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 67% above the current price.
Score: 3.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Checks not passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year average ROIC above 12%
- More cash than debt, or low debt to equity
- Debt below 3 years of free cash flow
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.4B | $17.4B | $15.8B | $14.3B | $13.4B | $12.6B | $11.6B | $11.4B | $10.8B | $11.3B | $10.5B |
| Net income | $1.5B | $1.5B | $1.1B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M |
| Free cash flow | $1.1B | $849M | $1.1B | $525M | $262M | $28M | $1.6B | $804M | $610M | $690M | $814M |
| EPS (diluted) | $23.88 | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 |
| Net margin | 8.0% | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 6.7% | 6.7% |
| ROIC | — | 12.3% | 11.2% | 7.8% | 6.8% | 9.8% | 9.8% | 9.6% | 9.7% | 9.6% | 9.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 17 analysts is $195.24, 1% above the current price; targets range from $156.00 to $250.00; the consensus rating is “Buy”; expected EPS is $22.44 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Universal Health Services’s P/E ratio?
About 8.1, based on the last twelve months of diluted earnings per share (forward P/E about 8.6).
Is Universal Health Services stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 67% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Universal Health Services pay a dividend?
Yes. The dividend yield is about 0.41%, and it has paid dividends for 10 years in our data.
Is Universal Health Services a good stock to buy?
We do not give buy or sell advice. Universal Health Services scores 3.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.